Author

Robin Lockhorst

Observed name: R. Lockhorst

Institution: Avera Health

Observed institutions: Avera Health, Avera McKennan Hospital & University Health Center

OpenAlex ID: A5019738715

Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group

2022 · Heidi D Finnes, Berrie Child, et al. · American Journal of Health-System Pharmacy · 24

Evaluating the use of appropriate anticoagulation with lenalidomide and pomalidomide in patients with multiple myeloma

2018 · Sarah M Anderson, Bradley Beck, et al. · Journal of Oncology Pharmacy Practice · 11

Standardization of key performance indicators and metrics for investigational drug services: Consensus recommendations among IDS specialists

2024 · Molly Schmidt, Lisa Janssen Carlson, et al. · American Journal of Health-System Pharmacy · 1

Evaluation of Factors Affecting Clinical Trial Consideration and Enrollment for Cancer Patients.

2026 · Logan Stacey, Bing Xu, et al. · PubMed

Evaluating the role of social determinants of health in consideration of patient selection for gynecologic cancer treatment trials: A community cancer center perspective

2025 · Casey Williams, Logan Stacey, et al. · Gynecologic Oncology

Characterization of social determinants of health in patients considered for participation in treatment clinical trials at a community cancer center serving the Great Plains.

2024 · Logan Stacey, Bing Xu, et al. · Journal of Clinical Oncology

Early results of a phase I evaluation of TAK-228 (TORC 1/2 inhibitor) in combination with TAK-117 (PI3K alpha inhibitor) and paclitaxel in advanced gynecologic malignancies and metastatic breast cancer

2019 · C.B. Williams, K.A. Williams, et al. · Gynecologic Oncology

An Algorithm to Facilitate Successful and Cost Effective Hematopoietic Progenitor Cell (HPC) Harvests Based on Peripheral Blood HPC CD34 Counts

2014 · Ramakrishnan Parameswaran, Leslie Cooper, et al. · Transplantation and Cellular Therapy

Works count: 8

Citation count: 36

H-index: 2

I10-index: 2